Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.

Gaber A, Johansson M, Stenman UH, Hotakainen K, Pontén F, Glimelius B, Bjartell A, Jirström K, Birgisson H.

Br J Cancer. 2009 May 19;100(10):1540-8. doi: 10.1038/sj.bjc.6605047. Epub 2009 Apr 21.

PMID:
19384300
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Gaber A, Nodin B, Hotakainen K, Nilsson E, Stenman UH, Bjartell A, Birgisson H, Jirström K.

BMC Cancer. 2010 Sep 17;10:498. doi: 10.1186/1471-2407-10-498.

PMID:
20849596
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.

Koskensalo S, Hagström J, Louhimo J, Stenman UH, Haglund C.

Oncology. 2012;82(4):234-41. doi: 10.1159/000336080. Epub 2012 Apr 12.

PMID:
22508321
[PubMed - indexed for MEDLINE]
4.

Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.

Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC.

Eur J Cancer. 2007 Mar;43(4):736-44. Epub 2007 Jan 30.

PMID:
17267202
[PubMed - indexed for MEDLINE]
5.

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

Larsson A, Johansson ME, Wangefjord S, Gaber A, Nodin B, Kucharzewska P, Welinder C, Belting M, Eberhard J, Johnsson A, Uhlén M, Jirström K.

Br J Cancer. 2011 Aug 23;105(5):666-72. doi: 10.1038/bjc.2011.295. Epub 2011 Aug 9.

PMID:
21829192
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.

Gaber A, Stene C, Hotakainen K, Nodin B, Palmquist I, Bjartell A, Stenman UH, Jeppsson B, Johnson LB, Jirström K.

Radiat Oncol. 2011 Aug 24;6:100. doi: 10.1186/1748-717X-6-100.

PMID:
21864386
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.

Venesmaa P, Lehtovirta P, Stenman UH, Leminen A, Forss M, Ylikorkala O.

Br J Cancer. 1994 Dec;70(6):1188-90.

PMID:
7981075
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Kokkola A, Stenman UH, Haglund C.

Histopathology. 2005 Apr;46(4):380-8.

PMID:
15810949
[PubMed - indexed for MEDLINE]
9.

Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.

Solakidi S, Tiniakos DG, Petraki K, Stathopoulos GP, Markaki I, Androulakis G, Sekeris CE.

Histol Histopathol. 2003 Oct;18(4):1181-8.

PMID:
12973686
[PubMed - indexed for MEDLINE]
10.

Tumour budding at invasive margins and outcome in colorectal cancer.

Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T, Watanabe M.

Colorectal Dis. 2008 Jan;10(1):41-7.

PMID:
18078460
[PubMed - indexed for MEDLINE]
11.

The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.

Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG.

World J Surg Oncol. 2007 Mar 9;5:31.

PMID:
17349047
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.

Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR.

PLoS One. 2011 Feb 24;6(2):e16636. doi: 10.1371/journal.pone.0016636.

PMID:
21383983
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
[PubMed - indexed for MEDLINE]
14.

Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.

Pasanen P, Eskelinen M, Kulju A, Penttilä I, Janatuinen E, Alhava E.

Scand J Clin Lab Invest. 1995 Apr;55(2):119-24.

PMID:
7667604
[PubMed - indexed for MEDLINE]
15.

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH.

Clin Cancer Res. 2004 Jul 15;10(14):4761-8.

PMID:
15269150
[PubMed - indexed for MEDLINE]
Free Article
16.

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T.

Br J Cancer. 2010 Mar 2;102(5):908-15. doi: 10.1038/sj.bjc.6605558. Epub 2010 Feb 9.

PMID:
20145615
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.

Lin Q, Wei Y, Zhong Y, Zhu D, Ren L, Xu P, Zheng P, Feng Q, Ji M, Lv M, Liang C, Xu J.

Tumour Biol. 2014 Oct;35(10):9743-50. doi: 10.1007/s13277-014-2267-4. Epub 2014 Jun 28.

PMID:
24972972
[PubMed - indexed for MEDLINE]
18.

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.

Larsson A, Fridberg M, Gaber A, Nodin B, Levéen P, Jönsson G, Uhlén M, Birgisson H, Jirström K.

BMC Cancer. 2012 Jul 8;12:282. doi: 10.1186/1471-2407-12-282.

PMID:
22769594
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.

Koskensalo S, Louhimo J, Hagström J, Lundin M, Stenman UH, Haglund C.

PLoS One. 2013 Oct 25;8(10):e76906. doi: 10.1371/journal.pone.0076906. eCollection 2013.

PMID:
24204699
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.

Lyytinen I, Lempinen M, Nordin A, Mäkisalo H, Stenman UH, Isoniemi H.

Scand J Gastroenterol. 2013 Sep;48(9):1066-73. doi: 10.3109/00365521.2013.805810. Epub 2013 Jul 29.

PMID:
23889187
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk